Back to browse

EXP001177

Paper

Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy (2021)

Peptide

CPP

Sequence: CKRRMKWKK

RNA

siRNA

All experiment fields

Experiment Id EXP001177
Paper Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for imp
Peptide CPP
Delivery Success Class no
In Vivo Flag yes
Uptake Confirmed no
Label Confidence high
In Vitro Functional Effect yes
Endosomal Escape Evidence
Peptide Concentration CPP covalently linked to siRNA (CPP–siRNA)
Rna Concentration 100 nM siRNA; 4 h treatment then 48 h before qRT-PCR
Mixing Ratio Equimolar CPP and siRNA during conjugation (reported 6 µM synthesis conditions)
Formulation Format Free CPP–siRNA conjugate (no carrier)
Formulation Components CPP–siRNA conjugate prepared via disulfide linkage
Size Nm
Zeta Mv
Model Scope in_vivo
Model Type in vitro
Cell Lines Or Primary Cells HT-1080 human fibrosarcoma cells
Animal Model
Administration Route
Output Type In vitro functional RNA effect (qRT-PCR c-myc mRNA suppression)
Output Value Improved c-myc suppression vs free siRNA
Output Units
Output Notes CPP conjugation increased gene silencing compared with free siRNA.
Toxicity Notes
Curation Notes